KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Change in Cash (2017 - 2025)

Cardlytics (CDLX) has disclosed Change in Cash for 9 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 441.32% year-over-year to $4.8 million, compared with a TTM value of -$16.9 million through Dec 2025, up 35.68%, and an annual FY2025 reading of -$16.9 million, up 35.68% over the prior year.
  • Change in Cash was $4.8 million for Q4 2025 at Cardlytics, up from -$2.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $320.3 million in Q1 2021 and bottomed at -$362.9 million in Q2 2021.
  • Average Change in Cash over 5 years is -$12.2 million, with a median of -$4.8 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 14075.13% in 2021, while the deepest fall reached 9401.18% in 2021.
  • Year by year, Change in Cash stood at -$3.9 million in 2021, then plummeted by 323.76% to -$16.6 million in 2022, then surged by 110.18% to $1.7 million in 2023, then crashed by 182.49% to -$1.4 million in 2024, then skyrocketed by 441.32% to $4.8 million in 2025.
  • Business Quant data shows Change in Cash for CDLX at $4.8 million in Q4 2025, -$2.8 million in Q3 2025, and -$5.3 million in Q2 2025.